Aug 7, 2026, 11:43 AM ETFinancial Services

BCB Bancorp — Q2 2026 Earnings Summary

BCBPBCB BANCORP INC

Financial Performance

The net margin increased by approximately 8 basis points to over 3%.
The quarter included a $5.3 million goodwill write-off, which was the only intangible asset on the balance sheet.
Loan loss provisioning for the quarter totaled $19 million, with $16.7 million dedicated to the C&I loan portfolio (excluding Business Express loans).
C&I loan portfolio losses increased to approximately $5.8 million in the second quarter, up from $0.8 million in the first quarter.
Business Express loan losses were $1.1 million year-to-date in 2026, compared to $10 million in 2025 and a similar amount in 2024.
The Business Express portfolio has a reserve coverage of 15%.
The company reported consistent operating revenue of approximately $25 million per quarter over the last five quarters, totaling $100 million.
Deferred Tax Assets (DTA) on the balance sheet are approximately $25 million.
Past due loans total approximately $122 million; specific breakdowns between 60-89 days and 90+ days are pending in the upcoming quarterly filing.
Cannabis loans, totaling approximately $69–$70 million, are not in the past due bucket.
Subordinated debt outstanding is approximately $40 million.

Management aims to complete the financial restructuring work and have it announced by the end of the third quarter.
Management expects to provide meaningful clarity regarding capital needs, portfolio status, and future plans around Labor Day.
Operating expenses are expected to remain elevated for a couple of quarters due to consultant and legal fees, with a goal to normalize by 2027.
The long-term goal is to cleanse the financial statements of uncertainty to establish a clear path forward for the fourth quarter and the 2027 fiscal year.
Management does not expect a major recovery in the C&I portfolio and has removed that expectation.
Management does not plan to grow the balance sheet until financial needs are fully understood.

The company exited the consumer business; the remaining legacy portfolio has behaved well and has not warranted significant attention.
The Business Express loan portfolio is considered a "weak portfolio" but has seen moderated write-offs in the last couple of months.
The C&I portfolio review is approximately halfway complete.
The Commercial Real Estate (CRE) portfolio review is ongoing, with the vast majority of loans still under review.
Cannabis loans are primarily classified within CRE with real estate collateral, often involving specialty properties.
The company is actively reviewing the criticized and classified loan levels, which remain high despite a slight decrease.

Management cites an attractive geographic footprint and believes there is a reasonably good market for deposit growth, though balance sheet expansion is paused.
The company notes that credit issues stem from aggressive growth starting around 2020 through early 2024, entering businesses not fully understood.
Management acknowledges that some credit issues resulted from poor pricing and core structure issues rather than just market conditions.

The holding company faces a significant challenge regarding the absolute level of double leverage.
There is uncertainty regarding the holding company's ability to service debt and the cost of that debt.
The company faces potential future charge-offs in the C&I and CRE portfolios as reviews continue.
The binary nature of Business Express loans means that once a credit fails, it is often a total loss.
The holding company structure complicates capital management and liquidity options.
There is a risk that Deferred Tax Assets may require a valuation reserve if it is determined they are unlikely to be utilized, though management currently does not anticipate this.
Deferring interest on subordinated debt would constitute an event of default.

CEO Thomas O'Brien described the current situation as a "major undertaking" and emphasized a "very critical look" at each credit portfolio.
Management expressed a commitment to transparency, stating they will "err on the side of keeping the bank well capitalized."
O'Brien noted that while the first few weeks were difficult, recent weeks have shown "good surprises" and "a little better" sentiment.
Management admitted to getting "a little too deep" into businesses they did not fully understand and acknowledged poor pricing and structuring in the past.
The tone is cautious and focused on "cleansing" the balance sheet rather than immediate growth.

Analysts inquired about the scope of the C&I and CRE reviews; management confirmed the Business Express review was comprehensive, while C&I is halfway done and CRE is ongoing.
Questions regarding the DTA were answered with the view that it will be utilized efficiently once the balance sheet is cleaned up.
Analysts asked about the holding company structure; management confirmed it complicates liquidity and capital decisions.
Discussion covered the potential for debt-for-equity swaps or converting preferreds to common stock, though no definitive plans were announced.
Management confirmed there are no regulatory orders currently in place and relations with regulators are "quite good."

The company suspended dividends on both common and preferred shares to retain liquidity at the holding company and build capital at the bank.
The Board has determined to change the state of incorporation to Delaware and eliminate staggered terms of office for directors to modernize the corporate structure.
The company brought in consultants to assist with the financial restructuring and risk rating reviews.
Equity compensation received by the new CEO was counted in fully diluted shares on day one, impacting tangible book value.
Management is modeling various scenarios to address the holding company's debt and preferred obligations, including potential debt-for-equity swaps.